Product Information
PHENYTOIN 50 MG TABLET CHEW is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2012 per EA under NDC 64980057301. Its NADAC has been published 109 times since Sep 4, 2024.
FDA first approved this application on Dec 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980057301
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENYTOINApproval Type
Generic (ANDA)
FDA Application
ANDA200691FDA Approved
12/26/2012
TE Code
AB
On Market Since
5/3/2024
Pharmacological Classes
Price Statistics
The NADAC for PHENYTOIN 50 MG TABLET CHEW has been published 109 times since Sep 4, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2012 per EA |
|---|---|
| All-time high | $0.2491 (Nov 13, 2024) |
| All-time low | $0.1793 (Nov 19, 2025) |
| 52-week high | $0.2128 |
| 52-week low | $0.1793 |
| Median price | $0.2128 |
| Average price | $0.2099 |
| Largest weekly change | +14.1% (Sep 18, 2024) |
| Weeks tracked | 109 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenytoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENYTOIN 50 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for PHENYTOIN 50 MG TABLET CHEW, manufactured by Rising Pharma Holdings Inc., is $0.2012 per EA (NDC 64980057301), effective Sep 30, 2026.
How has the price of PHENYTOIN 50 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for PHENYTOIN 50 MG TABLET CHEW has held within roughly two percent of its current level. It has been tracked across 109 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for PHENYTOIN 50 MG TABLET CHEW?
Since Sep 4, 2024, the NADAC for PHENYTOIN 50 MG TABLET CHEW has ranged from a low of $0.1793 (Nov 19, 2025) to a high of $0.2491 (Nov 13, 2024), with a median of $0.2128 per EA.
Are there cheaper alternatives to PHENYTOIN 50 MG TABLET CHEW?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENYTOIN 50 MG TABLET CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENYTOIN 50 MG TABLET CHEW?
PHENYTOIN 50 MG TABLET CHEW (NDC 64980057301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.